Beyond Attribution: The Future of Measurement in Pharma Marketing

Pharmaceutical marketers face a measurement dilemma. Traditional attribution models often promise clear answers, yet the reality of modern engagement is far more complex. Physicians...

The AI Launch Era: Preparing Pharma Marketing for Algorithm-Driven Market Entry

What if your next drug launch isn’t judged first by physicians, but by algorithms? That shift is already happening. Today, an effective AI pharma...

The Science of Influence: Using Behavioral Economics to Improve Pharma Marketing

Prescribing decisions rarely happen in a purely rational way. Even though clinical evidence plays a central role, physicians often rely on mental shortcuts, experience,...

Owning the Disease Conversation: The New Playbook for Therapeutic Area Leadership

Pharmaceutical brands no longer compete only on product performance. Instead, many now compete to shape the broader conversation around disease understanding and patient education....

Real-World Evidence Marketing: Turning Clinical Data Into Commercial Influence

Real-world data is everywhere in healthcare today. Hospitals collect outcomes data, patient registries track long-term treatment results, and insurers analyze therapy effectiveness at scale....

The Public Health Pivot: How Pharma Brands Are Partnering with Governments to Drive Impact

Pharmaceutical companies have traditionally focused on developing and marketing therapies. However, healthcare systems now face challenges that demand broader collaboration. Governments, public health agencies,...

From Support to Strategy: How Patient Support Programs Are Reshaping Pharma Marketing

Patient support programs were once viewed as helpful services that assist patients after a prescription is written. However, the healthcare landscape has changed dramatically....

The Medical Affairs Revolution: Why Scientific Engagement Is Becoming Pharma Marketing’s Strategic Core

For decades, pharmaceutical marketing teams controlled the narrative around clinical evidence, product positioning, and brand messaging. Today, however, that dynamic is shifting. A new pharma...

The Talent Equation: Where Pharma Marketing Capabilities Should Live in the AI Era

Artificial intelligence is changing the pace of pharmaceutical marketing. Campaigns that once required weeks of production can now move from concept to launch in...

One Story, Two Audiences: Aligning Wall Street Expectations with Brand Messaging

Investor expectations now shape how pharmaceutical companies communicate about pipelines, pricing, and long-term growth. Because of this shift, alignment between pharma investor relations and...